2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 74, n° 1
pages 190-192 (janvier 2016)
Doi : 10.1016/j.jaad.2015.08.057

Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States

Melissa J. Danesh, BS a, Alexa B. Kimball, MD, MPH b,
a University of California, San Francisco, School of Medicine, San Francisco, California 
b Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts 

Reprint requests: Alexa B. Kimball, MD, MPH, Department of Dermatology, Massachusetts General Hospital, 50 Staniford St, Boston, MA 02114.

Key words : anti-IL-17RA, brodalumab, depression, economic recession, monoclonal antibody, suicidal ideation, suicide

 Funding sources: None.
 Disclosure: Dr Kimball has been a consultant and investigator for Amgen, Abbvie, Janssen, Novartis, Celgene, and Pfizer; has been a consultant for Eli Lilly; and has fellowship funding from Janssen. Ms Danesh has no conflicts of interest to declare.

Top of the page

© 2015  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline